Effect of octreotide on polycystic liver volume

Liver International

Volumn 30, Issue 4, 2010, Pages 633-634

  van Keimpema, Loes ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; OCTREOTIDE;

ABDOMINAL CRAMP; ADULT; AGED; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; ENZYME REPLACEMENT; FECES; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; LETTER; LIVER FUNCTION; LIVER POLYCYSTIC DISEASE; LIVER WEIGHT; MALE; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CYSTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; INJECTIONS, SUBCUTANEOUS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; OCTREOTIDE; ORGAN SIZE; RISK ASSESSMENT; SAMPLING STUDIES; TREATMENT OUTCOME;

EID: 77950599888     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02123.x     Document Type: Letter

References (7)

1. Bae KT, Zhu F, Chapman AB. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the consortium for radiologic imaging studies of polycystic kidney disease cohort. Clin J Am Soc Nephrol 2006, 1:64-9.
2. van Keimpema L, Hockerstedt K. Treatment of polycystic livers. Br J Surg 2009, in press
3. Arnold HL, Harrison SA. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol 2005, 100:2569-82.
4. van Keimpema L, de Koning DB, Strijk SP, Drenth JP. Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 2008, 53:2251-7.
5. van Keimpema L, Ruurda JP, Ernst MF, van Geffen HJ, Drenth JP. Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg 2008, 12:477-82.
6. Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 2007, 132:1104-16.
7. van Keimpema L, de Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008, 57:1338-9.